Poehler Diana, Czerniecki Joseph, Norvell Daniel, Henderson Alison, Dolan James, Devine Beth
Department of Health Services, University of Washington, Seattle, WA, USA.
Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
MDM Policy Pract. 2022 Dec 15;7(2):23814683221143765. doi: 10.1177/23814683221143765. eCollection 2022 Jul-Dec.
Patients with chronic limb-threatening ischemia who are facing a lower-limb amputation often require a transmetatarsal amputation (TMA) or a transtibial amputation (TTA). A TMA preserves more of the patient's limb and may provide better mobility but has a lower probability of primary wound healing relative to a TTA and may result in additional amputation surgeries. Understanding the differences in how patients and providers prioritize key outcomes may enhance the amputation decisional process. To develop and pilot test a multiple criteria decision analysis (MCDA) tool to elicit patient values around amputation-level selection and compare those with provider perceptions of patient values. We conducted literature reviews to identify and measure the performance of criteria important to patients. Because the quantitative literature was sparse, we developed a Sheffield elicitation framework exercise to elicit criteria performance from subject matter experts. We piloted our MCDA among patients and providers to understand tool acceptability and preliminarily assess differences in patient and provider priorities. Five criteria of importance were identified: ability to walk, healing after amputation surgery, rehabilitation intensity, limb length, and prosthetic/orthotic device ease. Patients and providers successfully completed the MCDA and identified challenges in doing so. We propose potential solutions to these challenges. The results of the pilot test suggest differences in patient and provider outcome priorities. The pilot test study enrolled a small sample of providers and patients. We successfully implemented the pilot study to patients and providers, received helpful feedback, and identified solutions to improve the tool. Once modified, our MCDA tool will be suitable for wider rollout.
Patients and providers have successfully completed our MCDA, and patients feel the MCDA may be useful in clinical practice.We encountered several methodologic challenges and identified approaches to ease participant burden.When data are sparse, using the Sheffield elicitation framework is helpful in creating a performance matrix, although patients relied largely on their amputation experiences to complete the exercise. Blinding the alternatives may help patients better understand the process.
面临下肢截肢的慢性肢体威胁性缺血患者通常需要进行经跖骨截肢(TMA)或经胫骨截肢(TTA)。TMA能保留患者更多的肢体部分,可能提供更好的活动能力,但相对于TTA,其一期伤口愈合的概率较低,并且可能导致额外的截肢手术。了解患者和医疗服务提供者在如何对关键结果进行优先级排序方面的差异,可能会改善截肢决策过程。开发并试点测试一种多标准决策分析(MCDA)工具,以引出患者在截肢水平选择方面的价值观,并将其与医疗服务提供者对患者价值观的认知进行比较。我们进行了文献综述,以识别和衡量对患者重要的标准的表现。由于定量文献稀少,我们开发了一种谢菲尔德引出框架练习,以从主题专家那里引出标准表现。我们在患者和医疗服务提供者中试点了我们的MCDA,以了解工具的可接受性,并初步评估患者和医疗服务提供者在优先级方面的差异。确定了五个重要标准:行走能力、截肢手术后的愈合情况、康复强度、肢体长度以及假肢/矫形器的易用性。患者和医疗服务提供者成功完成了MCDA,并指出了这样做时遇到的挑战。我们提出了应对这些挑战的潜在解决方案。试点测试的结果表明患者和医疗服务提供者在结果优先级方面存在差异。试点测试研究纳入了一小部分医疗服务提供者和患者。我们成功地将试点研究应用于患者和医疗服务提供者,收到了有用的反馈,并确定了改进工具的解决方案。一旦修改,我们的MCDA工具将适合更广泛的推广。
患者和医疗服务提供者成功完成了我们的MCDA,患者认为MCDA在临床实践中可能有用。我们遇到了几个方法学上的挑战,并确定了减轻参与者负担的方法。当数据稀少时,使用谢菲尔德引出框架有助于创建一个表现矩阵,尽管患者在很大程度上依赖他们的截肢经历来完成这项练习。对备选方案进行盲法处理可能有助于患者更好地理解这个过程。